Moreover, they show that metformin enhances the expression of the genes encoding the receptors for both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) in mouse islets and also increases the effects of GIP and GLP-1 on insulin secretion from beta cells
Interestingly, the same study found that, in rats, tirzepatide suppressed lipid intake without affecting sucrose (carbohydrate) consumption in a choice-based assay, implying that the effects of these medications may be macronutrient specific (Geisler et al., 2023)
What this means for brands Develop nutrientdense products adapted to smaller portions Combine protein and fiber to support satiety and muscle preservation Address digestive comfort and energy levels as part of the overall experience Preserve taste and texture despite reformulation constraints Several recent launches already illustrate how brands are responding to this shift in consumer needs: Nutrient density in smaller portions Goodness introduces Vital Pursuit Meals, a range specifically designed for consumers whose eating habits are shaped by GLP1driven appetite changes
The metabolism of carnitine by the intestinal flora and its impact on cardiovascular health has become a research hotspot
Vials with rubber stoppers and flip-off caps do not pose the same glass fragment risk
Withdrawal Times: None